(CNN) Biotechnology company Regeneron released some early results of tests using its antibody cocktail in coronavirus patients Tuesday, and said it seemed to reduce levels of the virus and improve symptoms in patients. The numbers in this early release of information were small and the data has not been peer reviewed yet. A company spokesperson said the data validates the treatment as a therapeutic substitute for a natural response to the virus. A cocktail antibody therapy uses two or more lab-engineered antibodies. Eli Lilly is also in late stage trials with its antibody treatment.

Source: CNN September 29, 2020 20:03 UTC